武聚山，主任醫(yī)師，醫(yī)學(xué)博士。北京醫(yī)學(xué)會(huì)器官移植學(xué)分會(huì)委員，北京醫(yī)學(xué)會(huì)外科學(xué)分會(huì)肝臟外科學(xué)組委員，中國醫(yī)療保健國際交流促進(jìn)會(huì)肝臟腫瘤分會(huì)青委員。長期從事肝臟腫瘤及肝硬化門脈高壓臨床工作，在終末期肝病和肝癌肝移植方面有豐富臨床經(jīng)驗(yàn)。承擔(dān)首都衛(wèi)生發(fā)展科研專項(xiàng)基金1項(xiàng)，首都醫(yī)科大學(xué)基礎(chǔ)與臨床科研基金課題1項(xiàng)。長期從事肝臟腫瘤及肝硬化門脈高壓臨床工作，在終末期肝病和肝癌肝移植方面有豐富臨床經(jīng)驗(yàn)。

代表性研究：

[1] Jiliang Feng, Junmei Chen, Ruidong Zhu, Lu Yu, Yan Zhang, Dezhao Feng, Heli Kong, Chenzhao Song, Hui Xia, Jushan Wu, Dawei Zhao;Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection. Oncotarget; 2017 Sep 8; 8(38): 63299–63310.[2] Qing-Fen Zheng, Jing-Yun Zhang, Ju-Shan Wu, Ying Zhang, Mei Liu, Li Bai, Jin-Yan Zhang, Jing Zhao, Yu Chen, Zhong-Ping Duan, Su-Jun Zheng;, Upregulation of miRNA-130a Represents Good Prognosis in Patients With HBV-Related Acute-on-Chronic Liver Failure: A Prospective Study. Medicine (Baltimore); 2016 Feb; 95(6): e2639.[3] Degang Kong, Xiuli Chen, Shichun Lu, Qingliang Guo, Wei Lai, Jushan Wu, Dongdong Lin, Daobing Zeng, Binwei Duan, Tao Jiang, Jilei Cao; Short-term effects of splenectomy on serum fibrosis indexes in liver cirrhosis patients. Int J Clin Exp Pathol; 2015 Nov; 8(11): 15260–15264.[4] Wei Lai, Shi-Chun Lu, Guan-Yin Li, Chuan-Yun Li, Ju-Shan Wu, Qing-Liang Guo, Meng-Long Wang, Ning Li,;Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization. World J Gastroenterol; 2012 Jul 14; 18(26): 3443–3450

[5] Jiliang Feng, Jushan Wu, Ruidong Zhu, Dezhao Feng, Lu Yu, Yan Zhang, Dayu Bu, Chenlei Li, Yuyan Zhou, Lianghao Si, Yuhan Liu, Ziwei Liang, Jianing Xu, Tianjun Wu; Simple Risk Score for Prediction of Early Recurrence of Hepatocellular Carcinoma within the Milan Criteria after Orthotopic Liver Transplantation. Sci Rep; 2017 Mar; 7: 44036.[6]武聚山,段斌煒,李娟,金愛華,朱躍科,于紅衛(wèi),孟慶華.Fibroscan檢測對(duì)慢性HBV感染者肝纖維化臨床分期的預(yù)測價(jià)值[J].中華傳染病病雜志,2017,(8):498-500.[7]武聚山,李磊,宋艷明,封莉,李冰.肝硬化患者經(jīng)內(nèi)鏡逆行胰膽管造影治療的安全性分析[J].臨床肝膽病雜志,2014,(12):1267-1271.[8]武聚山,盧實(shí)春,王孟龍,李寧,夏仁品,郭慶良,賴威,張毅,楊光,劉源.肝移植治療原發(fā)性肝癌103例療效觀察[J].中華肝膽外科雜志,2009,15(10):748-750.